Cypress Sharpridge Investments, Inc. Prices Initial Public Offering.NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- Cypress Sharpridge Investments, Inc. (NYSE NYSE See: New York Stock Exchange : CYS) announced today the pricing of its initial public offering of 9,100,000 shares of common stock at $11.00 per share. The shares will be listed on the New York Stock Exchange New York Stock Exchange (NYSE) World's largest marketplace for securities. The exchange began as an informal meeting of 24 men in 1792 on what is now Wall Street in New York City. under the symbol "CYS." The offering is expected to close on June 17, 2009. Barclays Capital Inc. is the sole book runner Book Runner The managing or lead underwriter who maintains the books of securities sold for a new issue. Notes: In other words, this person is the underwriter who "runs" the books. Often the book runner is given credit for the total size of the deal. for the offering. JMP JMP Jump JMP Java Memory Profiler JMP Joint Manpower Program JMP Joint Management Plan JMP Joint Marketing Program JMP JCL Manipulation Program JMP Joint Mission Planning (US DoD) JMP Joint Military Program Securities LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control and Stifel, Nicolaus & Company, Incorporated are co-lead managers and Oppenheimer & Co. Inc. is a co-manager for the offering. Cypress Sharpridge Investments has granted to the underwriters a 30 day option to purchase up to an additional 1,365,000 shares of common stock to cover over-allotments, if any. All of the shares in the initial public offering are being offered by Cypress Sharpridge Investments, and the proceeds of the offering will be used to invest in Agency RMBS RMBS Residential Mortgage-Backed Securities RMBS Rambus, Inc. (NASDAQ stock symbol) RMBS Russian Mortgage-Backed Securities on a leveraged basis. A registration statement relating to the initial public offering of common stock was declared effective by the U.S. Securities and Exchange Commission on June 11, 2009. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of such common stock in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The offering of these securities will be made only by means of a prospectus, a copy of which may be obtained by contacting Barclays Capital Inc., by mail c/o Broadridge Integrated Distribution Services, 1155 Long Island Avenue, Edgewood, NY 11717, by email at barclaysprospectus@broadridge.com or by telephone at 1 (888) 603-5847. About Cypress Sharpridge Investments, Inc. Cypress Sharpridge Investments, Inc. is a specialty finance company that invests on a leveraged basis exclusively in whole-pool residential mortgage pass-through certificates for which the principal and interest payments are guaranteed by Fannie Mae Fannie Mae: see Federal National Mortgage Association. , Freddie Mac or Ginnie Mae. Cypress Sharpridge Investments has elected to be taxed as a real estate investment trust for federal income tax purposes. Forward Looking Statements This press release contains forward looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 and other federal securities laws. These forward looking statements are based upon Cypress Sharpridge Investment's present expectations, but these statements are not guaranteed to occur. For example, because this offering has priced may imply that the offering will close, but the closing is subject to certain conditions customary in transactions of this type and may be delayed or may not occur at all. In addition, the underwriters' over-allotment option may imply that this option will be exercised; however, the underwriters are not under any obligation to exercise this option, or any portion of it, and may not do so. Investors should not place undue reliance upon forward looking statements. For further discussion of the factors that could affect outcomes, please refer to the "Risk Factors" section of the prospectus. |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion